作者: Xiao-Jun Yang , Chao-Qun Huang , Tao Suo , Lie-Jun Mei , Guo-Liang Yang
DOI: 10.1245/S10434-011-1631-5
关键词:
摘要: Background This randomized phase III study was to evaluate the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment peritoneal carcinomatosis (PC) from gastric cancer.